Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: An updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials

Interactive Cardiovascular and Thoracic Surgery

Volumn 18, Issue 5, 2014, Pages 646-654

  Ali Hassan Sayegh, Sadegh ^a   Mirhosseini, Seyed Jalil ^a,b   Rezaeisadrabadi, Mohammad ^a   Dehghan, Hamid Reza ^a   Sedaghat Hamedani, Farbod ^c   Kayvanpour, Elham ^c   Popov, Aron Frederik ^d   Liakopoulos, Oliver J ^e  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Antioxidant; Atrial fibrillation; Cardiac surgery

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; POLYUNSATURATED FATTY ACID; ANTIARRHYTHMIC AGENT; ANTIOXIDANT; UNSATURATED FATTY ACID;

CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART SURGERY; HEART VALVE SURGERY; HUMAN; INCIDENCE; LENGTH OF STAY; META ANALYSIS; OUTCOME ASSESSMENT; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; ATRIAL FIBRILLATION; DIET SUPPLEMENTATION; RISK; RISK FACTOR; TIME; TREATMENT OUTCOME;

ACETYLCYSTEINE; ANTI-ARRHYTHMIA AGENTS; ANTIOXIDANTS; ASCORBIC ACID; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; DIETARY SUPPLEMENTS; FATTY ACIDS, UNSATURATED; HUMANS; LENGTH OF STAY; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899574261     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivu020     Document Type: Review

References (35)

1. Omae T, Kanmura Y. Management of postoperative atrial fibrillation. J Anesth 2012;26:429-37.
2. Rostagno C. Atrial fibrillation in patients undergoing surgical revasculariza-tion: an update on pharmacologic prophylaxis. Cardiovasc Hematol Agents Med Chem 2012;10:325-38.
3. Rodrigo R. Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system. Front Physiol 2012;3:93.
4. Baker WL, Anglade MW, Baker EL, White CM, Kluger J, Coleman CI. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg 2009;35:521-7.
5. Von Schacky C. Omega-3 fatty acids: anti-arrhythmic, pro-arrhythmic, or both? Front Physiol 2012;3:88.
6. Rasoli S, Kakouros N, Harling L, Gukop P, Soni M, Athanasiou T et al. Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence? Cardiol Res Pract 2011;2011:164078.
7. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
8. Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E et al. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 2008; 29:625-31.
9. El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2007;133:7-12.
10. Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with preexisting moderate renal insufficiency. Can J Anaesth 2007;54:872-81.
11. Haase M, Haase-Fielitz A, Bagshaw SM, Reade MC, Morgera S, Seevenayagam S et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007; 35:1324-31.
12. Kim JC, Hong SW, Shim JK, Yoo KJ, Chun DH, Kwak YL Effect of N-acetylcysteine on pulmonary function in patients undergoing off-pump coronary artery bypass surgery. Acta Anaesthesiol Scand 2011;55:452-9.
13. Kazemi B, Akbarzadeh F, Safaei N, Yaghoubi A, Shadvar K, Ghasemi K. Prophylactic high-dose oral-N-acetylcysteine does not prevent atrial fibrillation after heart surgery: a prospective double blind placebo controlled randomized clinical trial. 2013;36:1211-9.
14. Eren N, Cakir O, Oruc A, Kaya Z, Erdinc L. Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Perfusion 2003;18:345-50.
15. Peker O, Peker T, Erdogan D, Ozaydin M, Kapan S, Sutcu R et al. Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting. J Cardiovasc Surg (Torino) 2008;49:527-31.
16. Orhan G, Yapici N, Yuksel M, Sargin M, Senay S, Yalçin AS et al. Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery. Heart Vessels 2006;21:42-7.
17. Ozaydin M, Icli A, Yucel H, Akcay S, Peker O, Erdogan D et al. Metoprolol vs. carvedilol or carvedilol plus N-acetylcysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study. Eur Heart J 2013;34:597-604.
18. Sandesara CM, Chung MK, Van Wagoner DR, Barringer TA, Allen K, Ismail HM et al. A randomized, placebo-controlled trial of omega-3fatty acids for inhibition of supraventricular arrhythmias after cardiac surgery: the FISH Trial. J Am Heart Assoc 2012;1:e000547.
19. Heidarsdottir R, Arnar DO, Skuladottir GV, Torfason B, Edvardsson V, Gottskalksson G et al. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 2010;12: 356-63.
20. Heidt MC, Vician M, Stracke SK, Stadlbauer T, Grebe MT, Boening A et al. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg 2009;57:276-80.
21. Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E et al. N-3 fatty acids for the prevention of atrialfibrillation after coronary artery bypass surgery-a randomized, controlled trial. J Am Coll Cardiol 2005;45: 1723-8.
22. Sorice M, Tritto FP, Sordelli C, Gregorio R, Piazza L. N-3 polyunsaturated fatty acids reduces post-operative atrial fibrillation incidence in patients undergoing "on-pump" coronary artery bypass graft surgery. Monaldi Arch Chest Dis 2011;76:93-8.
23. Saravanan P, Bridgewater B, West AL, O'Neill SC, Calder PC, Davidson NC Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 2010;3:46-53.
24. Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ et al. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA 2012;308:2001-11.
25. Farquharson AL, Metcalf RG, Sanders P, Stuklis R, Edwards JR, Gibson RA et al. Effect of dietary fish oil on atrial fibrillation after cardiac surgery. Am J Cardiol 2011;108:851-6.
26. Bjordahl PM, Helmer SD, Gosnell DJ, Wemmer GE, O'Hara WW, Milfeld DJ. Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients. Am J Surg 2012; 204:862-7; discussion 867.
27. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decrease the incidence of postoperative atrial fibrillation. Circ Res 2001;89:E32-8.
28. Papoulidis P, Ananiadou O, Chalvatzoulis E, Ampatzidou F, Koutsogiannidis C, Karaiskos T et al. The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump myocardial revascularization surgery: a single-center experience-a pilot study. Interact CardioVasc Thorac Surg 2011;12:121-4.
29. Eslami M, Badkoubeh RS, Mousavi M, Radmehr H, Salehi M, Tavakoli N et al. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J 2007;34:268-74.
30. Colby JA, Chen WT, Baker WL, Coleman CI, Reinhart K, Kluger J et al. Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery. Am J Health Syst Pharm 2011;68:1632-9.
31. Gu WJ, Wu ZJ, Wang PF, Aung LH, Yin RX. N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC Cardiovasc Disord 2012;12:10.
32. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996;94:390-7.
33. Armaganijan L, Lopes RD, Healey JS, Piccini JP, Nair GM, Morillo CA. Do omega 3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials. Clinics (Sao Paulo) 2011;66: 1923-8.
34. He Z, Yang L, Tian J, Yang K, Wu J, Yao Y. Efficacy and safety of omega-3 fatty acids for the prevention of atrial fibrillation: a meta-analysis. Can J Cardiol 2013;29:196-203.
35. Rasoli S, Kourliouros A, Harling L, Athanasiou T. Does prophylactic therapy with antioxidant vitamins have an effect on atrial fibrillation following cardiac surgery? Interact CardioVasc Thorac Surg 2011;13:82-5.